Talphera signals ~$200,000 annual U.S. CRRT procedures in 2027 market sizing as NEPHRO CRRT reaches 75% enrollment (NASDAQ:TLPH)
· seekingalpha.com
Talphera (TLPH) Q2 2026 earnings call recap: 75% NEPHRO CRRT enrollment, KDIGO tailwind, timelines to data/PMA, cash runway—read now.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...